首页> 美国卫生研究院文献>other >Pain and Other Non-Neurological Adverse Events in Children with Sickle Cell Anemia and Previous Stroke who Received Hydroxyurea and Phlebotomy or Chronic Transfusions and Chelation: Results from the SWiTCH Clinical Trial

【2h】

Pain and Other Non-Neurological Adverse Events in Children with Sickle Cell Anemia and Previous Stroke who Received Hydroxyurea and Phlebotomy or Chronic Transfusions and Chelation: Results from the SWiTCH Clinical Trial

机译：镰状细胞性贫血和先前卒中患儿接受羟基脲和放血或慢性输血和螯合的疼痛和其他非神经系统不良事件：SWiTCH临床试验的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo compare the non-neurological events in children with sickle cell anemia (SCA) and previous stroke enrolled in SWiTCH.

机译：目的比较镰状细胞性贫血（SCA）和先前参加SWiTCH的中风患儿的非神经系统事件。

著录项

期刊名称 other
作者
Ofelia Alvarez; Nancy A. Yovetich; J. Paul Scott; William Owen; Scott T. Miller; William Schultz; Alexandre Lockhart; Banu Aygun; Jonathan Flanagan; Melanie Bonner; Brigitta U. Mueller; Russell E. Ware;
展开▼
作者单位

展开▼
年(卷),期 -1(88),11
年度 -1
页码 932–938
总页数 18
原文格式 PDF
正文语种
中图分类
关键词
sickle cell anemia hydroxyurea transfusion pain acute chest syndrome;

机译：镰状细胞性贫血;羟基脲;输血;疼痛;急性胸综合症;

相似文献

外文文献
专利

1. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial [J] . AlvarezO., YovetichN.A., ScottJ.P., American Journal of Hematology . 2013,第11期

机译：接受羟基脲和静脉放血或长期输血和螯合的镰状细胞性贫血和先前卒中患儿的疼痛和其他非神经系统不良事件：SWiTCH临床试验的结果
2. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. [J] . Ware RE, Schultz WH, Yovetich N, Pediatric blood & cancer . 2011,第6期

机译：将输血中风改为羟基尿素（SWiTCH）：治疗镰状细胞性贫血，中风和铁超负荷患儿的III期随机临床试验。
3. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. [J] . Miller ST, Wright E, Abboud M, The Journal of pediatrics . 2001,第6期

机译：镰状细胞性贫血中风预防试验（STOP）期间慢性输血对疼痛和急性胸综合症发病率的影响。
4. Predictors of use of hydroxyurea and its impact on clinical and economic outcomes among children with sickle cell disease. [D] . Datar, Manasi. 2015

机译：镰状细胞病患儿中羟基脲的使用及其对临床和经济结果的影响的预测因素。
5. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): A Phase III randomized clinical trial for treatment of children with sickle cell anemia stroke and iron overload [O] . Russell E. Ware, William H. Schultz, Nancy Yovetich, -1

机译：脑卒中输血转换为羟基脲（开关）：治疗镰状细胞贫血中风和铁过载的儿童的AITI III随机临床试验
6. Stroke with transfusions changing to hydroxyurea (SWiTCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload [O] . Russell E. Ware, William H. Schultz, Nancy Yovetich, 2011

机译：脑卒中输血转换为羟基脲（开关）：治疗镰状细胞贫血，中风和铁过载的儿童的AITI III随机临床试验

Pain and Other Non-Neurological Adverse Events in Children with Sickle Cell Anemia and Previous Stroke who Received Hydroxyurea and Phlebotomy or Chronic Transfusions and Chelation: Results from the SWiTCH Clinical Trial

摘要

著录项

相似文献

相关主题

期刊订阅